PROVO, Utah — Tute Genomics, already a standard bearer in the clinical genomics industry, has added even more valuable experience and proven leadership to its team with the naming of Andrew Olson as vice president of sales. “Tute Genomics is uniquely positioned to lead the revolution in genome-guided precision medicine,” said Olson. “With the most […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced a new single-cell application for its C1TM system that improves whole genome sequencing of individual cells. Single-cell whole genome sequencing allows researchers to explore mutations in regulatory and protein coding regions of the genome in order to identify novel signatures within heterogeneous cell populations. This […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT:BTX), a leader in developing pluripotent stem-cell therapies and other technologies designed to address major unmet medical needs, today announced the appointment of Adi Mohanty to the position of Chief Operating Officer of the Company. Mr. Mohanty’s primary responsibilities will be to build BioTime’s business through the development of […]
ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with the acquisition expired on December 22, 2014, thereby completing the U.S. HSR Act antitrust notification and review requirement for the acquisition of the Company by Merck KGaA, Darmstadt, Germany. U.S. antitrust […]
Porvair Sciences has released a new 2015 catalogue that describes its popular range of high quality tissue culture treated plastics and consumable products for Epigenetics. Porvair Tissue Culture plastics are made to the highest international standards for material quality, surface optical polish, tissue culture treatment, sterility and pack integrity. All products are certified to be […]
Calif.– Bina Technologies, Inc. (Bina, Redwood City, CA, USA) announced today that they have been acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY). Bina Technologies1,2 is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets. Bina […]
CARLSBAD, CA — International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Court of Justice of the European Union (CJEU), the European Union’s highest court, has ruled in favor of the Company and that the Company’s core technology patent applications are not […]
Copenhagen — Exiqon A/S today launched the miRSIGN™ miR-21 Oncogene assay, a Research Use Only kit for measuring miR-21 levels in relation to two reference microRNAs in formalin-fixed, paraffin-embedded (FFPE) tissue samples, and the miRSIGN™ Colon Cancer assay, a Research Use Only kit for determining the presence of cancer cells in FFPE colon tissue samples. […]
CULVER CITY, CA — Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement with Sigma-Aldrich to explore the use of Indi Molecular’s PCC technology with Sigma-Aldrich’s line of biological tools. PCC (protein catalyzed capture) agent technology is a breakthrough process that produces synthetic […]
SOUTH SAN FRANCISCO, Calif., HINXTON, U.K. — A formal collaboration was announced today between the Wellcome Trust Sanger Institute, the European Bioinformatics Institute (EMBL-EBI) and Fluidigm Corporation (NASDAQ:FLDM) to accelerate the development of new methods for the analysis of single-cell genomics data. The Single Cell Genomics Centre (SCGC) on the Wellcome Trust Genome Campus will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
